Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers


Table: The Drug Front--the Battle Continues

Several other companies have targeted cancer therapies in development

Company (and Drug Name), Target and Status:

Abbott Laboratories (ABT-627)

Endothelin-A growth factor, in Phase 3 trials for prostate cancer

AstraZeneca (IRESSA)

An enzyme released by the EGF receptor, Phase 3 trial for lung cancer

Cell Genesys (GVAX)

Vaccine uses patient's tumor cells to stimulate immune system, Phase 2 for various cancers

Isis Pharmaceuticals (ISIS 3521)

RNA messenger protein that encourages cell growth, Phase 3 trials for lung cancer

Millennium Pharmaceuticals (LDP-341)

Enzyme that blocks cell death, Phase 2 trials for myeloma and leukemia

OSI, Genentech and Roche (OSI-774)

An enzyme released by the EGF receptor, Phase 2 for lung and head and neck cancers

Sugen/Pharmacia (SU5416)

Growth factor that stimulates blood vessel growth, Phase 3 trials for colon cancer

blog comments powered by Disqus